Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model As a Candidate for Treatment of Cutaneous Leishmaniasis



Eskandari SE1 ; Firooz A1 ; Nassirikashani M1 ; Jaafari MR2, 3 ; Javadi A1, 4 ; Miraminmohammadi A1 ; Valiankeshavarz H5, 6 ; Khamesipour A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Center for Research and Training in Skin Diseases and Leprosy (CRTSDL), Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  4. 4. School of Allied Sciences, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Center for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Arthropod-Borne Diseases Published:2018

Abstract

Background: Development of a topical treatment for cutaneous leishmaniasis (CL) is an important step in the improvement of lesion management. Amphotericin B (AmB) is effective against Leishmania species but it is toxic, a Nano-liposomal form of AmB with a size of about 100nm (Lip-AmB) was developed and showed to be effective against Leishmania major, and Leishmania tropica in vitro and against L. major in vivo in animal model. This study was designed to check the irritancy Draize test in rabbits and was completed in the Center for Research and Training in Skin Diseases and Leprosy, TUMS, in 2012. Methods: Twenty rabbits in 3 steps were housed individually with artificial lighting (12/12h light/dark). SinaAmpholeish cream or empty liposomes (prepared under GMP condition at Minoo Company, Tehran, Iran), was applied on a gauze patch and the patches were placed on the designated sites of the skin in the back of the rabbits. At 48 and 72h later, the erythema and oedema were checked, scored and recorded. Results: The erythema score in rabbits was 0.83+0.41 for the SinaAmpholeish and 0.5+0.55 for empty liposomes (P= 0.16). The average score for oedema was 0.67+0.52 for SinaAmpholeish and 0.33+0.52 for empty liposomes (P= 0.16). Conclusion: Based on skin irritancy reactions the topical formulation of SinaAmpholeish is safe and could be further checked in human trials. © 2018 Tehran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Efficacy of Intra-Lesional Injections of Meglumine Antimoniate Once a Week Vs. Twice a Week in the Treatment of Cutaneous Leishmaniasis Caused by L. Tropica in Iran: A Randomized Controlled Clinical Trial, PLoS Neglected Tropical Diseases (2022)
2. Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (Sinaampholeish) on Healthy Volunteers: Phase I Clinical Trial, Iranian Journal of Parasitology (2019)
3. Overexpression of Iron Super Oxide Dismutases A/B Genes Are Associated With Antimony Resistance of Leishmania Tropica Clinical Isolates, Iranian Journal of Parasitology (2022)
4. Pilot Study of Safety and Efficacy of Topical Liposomal Amphotericin B for Cutaneous Leishmaniasis Caused by Leishmania Major in Islamic Republic of Iran; [Etude Pilote Sur L'innocuite Et L'efficacite De L'amphotericine B Liposomale Topique Pour Le Traitement De La Leishmaniose Cutanee Causee Par Leishmania Major En Republique Islamique D'iran], Eastern Mediterranean Health Journal (2022)
5. Anti Leishmania Activity of Lucilia Sericata and Calliphora Vicina Maggots in Laboratory Models, Experimental Parasitology (2016)
6. Combination of Topical Liposomal Amphotericin B and Glucantime in Comparison With Glucantime Alone for the Treatment of Anthroponotic Cutaneous Leishmaniasis (Acl) Caused by Leishmania Tropica: Study Protocol for a Randomized, Controlled Trial, Iranian Journal of Microbiology (2021)
7. Insights Into the Trypanothione System in Antimony-Resistant and Sensitive Leishmania Tropica Clinical Isolates, Acta Tropica (2024)
8. Potent Antileishmanial Activity of Chitosan Against Iranian Strain of Leishmania Major (Mrho/Ir/75/Er): In Vitro and in Vivo Assay, Journal of Vector Borne Diseases (2018)
Experts (# of related papers)
View all Related Experts
Mahdi Mohebali (18)
Homa Hajjaran (12)
Other Related Docs
9. Old World Cutaneous Leishmaniasis in Iran: Clinical Variants and Treatments, Journal of Dermatological Treatment (2021)
10. Identification of Cβs and Odc Antimony Resistance Markers in Anthroponotic Cutaneous Leishmaniasis Field Isolates by Gene Expression Profiling, Parasite Epidemiology and Control (2025)
11. Upregulation of Antioxidant Genes in Antimony-Resistant Leishmania Tropica Clinical Isolates, Molecular Biology Reports (2025)
12. Photodynamic Therapy Using Toluidine Blue O (Tbo) Dye As a Photosensitizer Against Leishmania Major, Iranian Journal of Public Health (2021)
13. Gene Expression Analysis of Antimony Resistance in Leishmania Tropica Using Quantitative Real-Time Pcr Focused on Genes Involved in Trypanothione Metabolism and Drug Transport, Archives of Dermatological Research (2019)
14. Correlation Between Clinical Responses With the Drug-Susceptibility of Parasites in Iranian Cutaneous Leishmaniasis Caused by Leishmania Major, Tropical Biomedicine (2017)
15. An Overview of Leishmanization Experience: A Successful Control Measure and a Tool to Evaluate Candidate Vaccines, Acta Tropica (2019)
16. Expression Analysis of Activated Protein Kinase C Gene (Lack1) in Antimony Sensitive and Resistant Leishmania Tropica Clinical Isolates Using Real-Time Rt-Pcr, International Journal of Dermatology (2016)
17. The Role of Atp-Binding Cassette Transporter Genes Expression in Treatment Failure Cutaneous Leishmaniasis, AMB Express (2022)
18. Immune Response in Cutaneous Leishmaniasis Patients With Healing Vs. Non-Healing Lesions, Iranian Journal of Microbiology (2020)
19. Double-Blind Randomized Efficacy Field Trial of Alum Precipitated Autoclaved Leishmania Major (Alum-Alm) Vaccine Mixed With Bcg Plus Imiquimod Vs. Placebo Control Group, Iranian Journal of Parasitology (2015)
20. Comparative Mitochondrial Proteomics of Leishmania Tropica Clinical Isolates Resistant and Sensitive to Meglumine Antimoniate, Parasitology Research (2020)
21. Anti-Leishmanial Effects of Resveratrol and Resveratrol Nanoemulsion on Leishmania Major, BMC Microbiology (2022)
22. The Leishmanicidal Effect of Lucilia Sericata Larval Saliva and Hemolymph on in Vitro Leishmania Tropica, Parasites and Vectors (2021)
23. Post-Treatment Clinical Outcomes of Cutaneous Leishmaniosis in the Bam Area, South Eastern Iran: Analysis of Over 9,000 Cases, International Journal of Infectious Diseases (2015)
24. Comparison of P27 Gene Expression of Promastigote and Amastigote Forms of Leishmania Major (Mrho/Ir/75/Er) by Real-Time Rt-Pcr, Iranian Journal of Parasitology (2018)
25. Treatment of Resistant Visceral Leishmaniasis With Interferon Gamma in Combination With Liposomal Amphotericin B and Allopurinol, Parasitology International (2019)
26. Development of a Topical Liposomal Formulation of Amphotericin B for the Treatment of Cutaneous Leishmaniasis, International Journal for Parasitology: Drugs and Drug Resistance (2019)
27. The Geographical Distribution of Human Cutaneous and Visceral Leishmania Species Identified by Molecular Methods in Iran: A Systematic Review With Meta-Analysis, Frontiers in Public Health (2021)
28. Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania Major to Glucantime® by 2-Dimensional Electrophoresis, Iranian Journal of Parasitology (2015)
29. Economic Burden of Cutaneous and Visceral Lishmaniasis in Iran in 2013, Iranian Journal of Epidemiology (2017)
30. Comparative Expression Profile Analysis of Apoptosis-Related Mirna and Its Target Gene in Leishmania Major Infected Macrophages, Iranian Journal of Parasitology (2020)
31. Comparative Proteomic Profiling of Leishmania Tropica: Investigation of a Case Infected With Simultaneous Cutaneous and Viscerotropic Leishmaniasis by 2-Dimentional Electrophoresis and Mass Spectrometry, Iranian Journal of Parasitology (2015)
32. A Comparison Between the Effects of Glucantime, Topical Trichloroacetic Acid 50% Plus Glucantime, and Fractional Carbon Dioxide Laser Plus Glucantime on Cutaneous Leishmaniasis Lesions, Dermatology Research and Practice (2016)
33. The Role of Glcnac-Pi-De-N-Acetylase Gene by Gene Knockout Through Homologous Recombination and Its Consequences on Survival, Growth and Infectivity of Leishmania Major in in Vitro and in Vivo Conditions, Acta Tropica (2016)
34. Cloning, High-Level Gene Expression and Bioinformatics Analysis of Sp15 and Leif From Leishmania Major and Iranian Phlebotomus Papatasi Saliva As Single and Novel Fusion Proteins: A Potential Vaccine Candidate Against Leishmaniasis, Transactions of the Royal Society of Tropical Medicine and Hygiene (2021)
35. A Novel Non-Invasive Diagnostic Sampling Technique for Cutaneous Leishmaniasis, PLoS Neglected Tropical Diseases (2017)
36. Salivary Gland Antigens of Laboratory-Bred Phlebotomus Sergenti and Their Immunogenicity in Human Volunteers in Laboratory Condition, Asian Pacific Journal of Tropical Medicine (2020)
37. A Novel Strategy for Enhance Potentiation of Meglumine Antimoniate Against Leishmania Major in Vitro, Iranian Journal of Parasitology (2019)
38. The Role of Mpl and Imiquimod Adjuvants in Enhancement of Immune Response and Protection in Balb/C Mice Immunized With Soluble Leishmania Antigen (Sla) Encapsulated in Nanoliposome, Artificial Cells# Nanomedicine and Biotechnology (2018)
39. Associated-Risk Determinants for Anthroponotic Cutaneous Leishmaniasis Treated With Meglumine Antimoniate: A Cohort Study in Iran, PLoS Neglected Tropical Diseases (2019)
40. Treatment Failure in Cutaneous Leishmaniasis Patients Referred to the School of Public Health, Tehran University of Medical Sciences During 2008-2017, Journal of Arthropod-Borne Diseases (2020)
41. Niosomal Formulation of Amphotericin B Alone and in Combination With Glucantime: In Vitro and in Vivo Leishmanicidal Effects, Biomedicine and Pharmacotherapy (2019)